Who
TCG Crossover GP II, LLC
10% owner
Company insider
Files Form 4 as: 10% owner, Surrozen.
In numbers
- Trades disclosed
- 22
- Buys
- 10
- Sells
- 1
- Bought
- $4.9M
- Sold
- $6.9M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Jan 2026
- Last trade
- 22 Jul 2026
- Last filed
- 24 Jul 2026
Companies traded
Activity over time
1 Jan – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 24 Jul 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $3.5M162,500 at $21.25 | filing |
| 22 Jul 2026filed 24 Jul 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $3.5M162,500 at $21.25 | filing |
| 24 Mar 2026filed 25 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $1.3M53,329 at $24.69 | filing |
| 24 Mar 2026filed 25 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $1.3M53,329 at $24.69 | filing |
| 23 Mar 2026filed 25 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $190K7,612 at $24.90 | filing |
| 23 Mar 2026filed 25 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $190K7,611 at $24.90 | filing |
| 16 Mar 2026filed 16 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $15K595 at $24.99 | filing |
| 16 Mar 2026filed 16 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $15K595 at $24.99 | filing |
| 13 Mar 2026filed 16 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $441K17,717 at $24.88 | filing |
| 13 Mar 2026filed 16 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $441K17,716 at $24.88 | filing |
| 12 Mar 2026filed 16 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $155K6,187 at $24.99 | filing |
| 12 Mar 2026filed 16 Mar 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $155K6,187 at $24.99 | filing |
| 12 Feb 2026filed 13 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $13K547 at $23.86 | filing |
| 12 Feb 2026filed 13 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $13K546 at $23.86 | filing |
| 11 Feb 2026filed 13 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $209K8,882 at $23.58 | filing |
| 11 Feb 2026filed 13 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $209K8,881 at $23.58 | filing |
| 3 Feb 2026filed 3 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $48K2,178 at $21.94 | filing |
| 3 Feb 2026filed 3 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $48K2,177 at $21.94 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $7,825366 at $21.38 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Bought | $7,804365 at $21.38 | filing |
News
Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)SRZN · tickerreport.com · 14 Oct 2026Surrozen Sees Unusually Large Options Volume (NASDAQ:SRZN)SRZN · themarketsdaily.com · 12 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)SRZN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name TCG Crossover GP II, LLC; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.